Dupixent returns as top Rx, OTC brand for September

Dupixent is back on top of the list of Rx and over-the-counter (OTC) brands for the month of September, according to data released by iSpot.tv Tuesday afternoon.

The eczema and asthma treatment from Sanofi and Regeneron led the way with an impressions share of voice (SOV) of 5.17%, with 3 billion impressions in total.